NetworkNewsBreaks

TuesdayDec 10, 2019 1:19 pm

NetworkNewsBreaks – Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Commences Dosing in Estrogen Receptor Pilot Study

Eagle Pharmaceuticals (NASDAQ: EGRX) on Monday announced that it has initiated dosing in a pilot clinical study to evaluate the unique characteristics of fulvestrant, EGRX’s product candidate that has the potential to enhance estrogen receptor (“ER”) inhibition and improve patient outcomes. The company will utilize the results of the pilot study to advise the design of the pivotal trial, which Eagle anticipates will commence in 2020. “We are pleased that dosing is underway in our pilot study, and look forward to gathering data to determine the design of our future pivotal study in estrogen receptor positive breast cancer patients. We…

Continue Reading

TuesdayDec 10, 2019 1:17 pm

NetworkNewsBreaks – HEXO Corp. (TSX: HEXO) (NYSE: HEXO) Closes $70M Private Placement of Convertible Debentures

HEXO (TSX: HEXO) (NYSE: HEXO) recently announced the closing of its private placement of unsecured convertible debentures for total gross proceeds of $70 million. The group of investors that took part in the offering includes HEXO CEO Sebastien St-Louis, as well as HEXO directors Dr. Michael Munzar, Vincent Chiara, Nathalie Bourque and Adam Miron. Pursuant to the offering, the company issued a total of $70 million principal amount of 8% unsecured convertible debentures maturing on December 5, 2022. The debentures are convertible any time after December 7, 2020 and prior to maturity at a conversion price of $3.16 per share,…

Continue Reading

TuesdayDec 10, 2019 12:56 pm

NetworkNewsBreaks – VistaGen Therapeutics, Inc.’s (NASDAQ: VTGN) PH94B Receives FDA Fast Track Designation to Treat Social Anxiety Disorder

VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (“CNS”) diseases and disorders with high unmet need, today announced that it has received Fast Track designation U.S. Food and Drug Administration (“FDA”) for development of the company's PH94B neuroactive nasal spray for on-demand treatment of social anxiety disorder (“SAD”). VistaGen is currently preparing PH94B for phase 3 development. “The FDA's grant of Fast Track designation for development of PH94B for SAD, which to our knowledge is the FDA's first Fast Track designation for a SAD drug candidate, is another important regulatory milestone for…

Continue Reading

TuesdayDec 10, 2019 12:09 pm

NetworkNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Obtains $450,000 Purchase Order from Bus Operating Company for Uniden(R) UV350

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a developer and provider of cellular communications solutions for enterprise workers and first responders, today announced that it has received a $450,000 purchase order for a bus operating company to equip their fleet of buses with the Uniden(R) UV350. The Uniden(R) UV350 is the world’s first LTE in-vehicle communications device that boasts a Push-to-Talk Over Cellular (“PoC”) function, crystal-clear sound for voice calls, Android data applications and more. Per the news release, Siyata has announced $6.5M to $9.0M in new business opportunities for its portfolio of 4G PoC devices since the start of the…

Continue Reading

TuesdayDec 10, 2019 12:04 pm

NetworkNewsBreaks – SinglePoint, Inc. (SING) Secures Distributor Agreement with JTI USA, Initiating PrimeTime Little Cigars Sales at MJBIZCON

SinglePoint (OTCQB: SING) today announced it has signed on as a distributor for JTI USA, part of the JT Group of companies, a multibillion-dollar organization with presence in 130 countries. SinglePoint will begin sales and take orders for JTI’s “PrimeTime Little Cigars” during its attendance at the 2019 MJBIZCON being held at the Las Vegas Convention Center, December 11-13, at booth number C9132. “I’m excited and honored to be working with JTI to distribute PrimeTime Little Cigars... The opportunity to work with a global leader in this category is exciting and we are ready to expand Primetime’s U.S. market share…

Continue Reading

TuesdayDec 10, 2019 11:25 am

NetworkNewsBreaks – No Borders Inc. (NBDR) CEO to Present at LD Micro Main Event on December 11

No Borders (OTC: NBDR), an established multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products, this morning announced that its CEO and Chairman Joseph Snyder will be presenting at the 12th Annual LD Micro Main Event taking place Dec. 10-12, 2019, at the Luxe Sunset in Bel Air, California. Snyder will be providing a detailed review of the company’s SEC qualified Reg A offering and “NBDR 2020 Roadmap” at 3:00 PM PST on Wednesday, Dec. 11. In addition, company management will be hosting one on one investor meetings before and after the presentation. To book…

Continue Reading

TuesdayDec 10, 2019 10:51 am

NetworkNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) to Serve as Premier Sponsor, Present at the 12th Annual LD Micro Main Event; Subsidiary to Serve as Lead Sponsor of MJ Biz Con

Youngevity International (NASDAQ: YGYI), a leading omni-direct lifestyle company, this morning announced that it will be presenting at the 12th annual LD Micro Main Event on Wednesday, December 11 at 11:20 AM PST. YGYI president and CFO Dave Briskie will be presenting in front of a variety of institutional investors, family offices, and high net worth investors. In addition, Youngevity will serve as a premier sponsor of the event featuring Be the Change(TM) coffee and Josies Java House Coffee, two of the company owned brands. “LD Micro continues to be an integral part of our awareness campaign and we are…

Continue Reading

TuesdayDec 10, 2019 10:38 am

NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Reports 2019 Shareholder Meeting Results, Names Independent Director

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) this morning reported the detailed voting results from its 2019 Annual and Special Meeting of Shareholders that took place on December 9, 2019 in Toronto, Ontario. Michael La Brier, Navdeep Dhaliwal, Ronald Factor, Colin Moore and Kenneth R. McKinnon were elected to the board of directors of the company to serve until the next annual meeting of shareholders, or until their successors are elected or appointed. Other results include the appointment of KPMG LLP as auditors of the company until the next annual meeting and the approval of SPRWF’s Omnibus Long-Term…

Continue Reading

TuesdayDec 10, 2019 9:59 am

NetworkNewsBreaks – Marijuana Company of America, Inc. (MCOA) to Present at 12th Annual LD Micro Main Event

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, today announced that it will present at the 12th Annual LD Micro Main Event held on December 10-12, 2019 at the Luxe Sunset Boulevard Hotel in Bel Air, California. MCOA Principal Executive Officer Jesus Quintero and Director Robert Coale are scheduled to present 11:40 a.m. PT on Wednesday, December 11, 2019. The presentation will cover a corporate overview, including recent highlights, the hempSMART(TM) brand, and current developments. Coale and Quintero will also be available for one-on-one meetings with investors during the conference. To view the full press release,…

Continue Reading

TuesdayDec 10, 2019 9:25 am

NetworkNewsBreaks – MCTC Holdings Inc. (MCTC) Reports Positive Results from Hemp Extract-Based Alcohol Replacement Technology Testing

MCTC Holdings (OTC: MCTC), a science-forward, intellectual-property-focused company developing unique hemp-infusion technologies, this morning reported alcohol replacement technology test results for its Hemp You Can Feel(TM) technology, a groundbreaking hemp-based infusion intended as a replacement for alcohol in many beverages. MCTC announced separate test results on three new infusions, the Hemp You Can Feel(TM) technology in powder form, in a liquid concentrate form and in a premixed nonalcoholic cocktail formulation. In industry standard high-performance liquid chromatography (“HPLC”)-based potency testing conducted by licensed independent laboratories, hemp extract and cannabinoid levels were undetectable for all three preparations. Additional analysis intended to reveal…

Continue Reading